Kiora Pharmaceuticals (KPRX) Short Interest Ratio & Short Volume $2.73 +0.11 (+4.20%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$2.68 -0.05 (-1.83%) As of 08/22/2025 07:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Kiora Pharmaceuticals Short Interest DataKiora Pharmaceuticals (KPRX) has a short interest of 25,100 shares, representing 0.89% of the float (the number of shares available for trading by the public). This marks a -51.54% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 87,042 shares to cover all short positions.Current Short Interest25,100 sharesPrevious Short Interest51,800 sharesChange Vs. Previous Month-51.54%Dollar Volume Sold Short$65.26 thousandShort Interest Ratio0.1 Days to CoverLast Record DateJuly 31, 2025Outstanding Shares3,430,000 sharesFloat Size2,820,000 sharesShort Percent of Float0.89%Today's Trading Volume27,058 sharesAverage Trading Volume87,042 sharesToday's Volume Vs. Average31% Short Selling Kiora Pharmaceuticals? Sign up to receive the latest short interest report for Kiora Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartKPRX Short Interest Over TimeKPRX Days to Cover Over TimeKPRX Percentage of Float Shorted Over Time Kiora Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/31/202525,100 shares $65.26 thousand -51.5%0.9%0.1 $2.60 7/15/202551,800 shares $155.40 thousand -35.7%1.8%0.1 $3.00 6/30/202580,600 shares $232.13 thousand -44.2%2.9%0.2 $2.88 6/15/2025144,500 shares $436.39 thousand +760.1%5.1%0.3 $3.02 5/31/202516,800 shares $51.07 thousand -33.3%0.6%0 $3.04 5/15/202525,200 shares $78.88 thousand -13.1%0.9%2.1 $3.13 4/30/202529,000 shares $93.38 thousand -9.7%1.0%1.4 $3.22 4/15/202532,100 shares $89.56 thousand -10.1%1.2%1.4 $2.79 3/31/202535,700 shares $107.46 thousand -34.6%1.3%1.2 $3.01 3/15/202554,600 shares $176.90 thousand +7.9%2.0%1.5 $3.24 Get the Latest News and Ratings for KPRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Kiora Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 2/28/202550,600 shares $164.45 thousand -29.8%1.8%1.2 $3.25 2/15/202572,100 shares $261.00 thousand +281.5%2.6%1.7 $3.62 1/31/202518,900 shares $76.17 thousand +9.3%0.7%0.4 $4.03 1/15/202517,300 shares $58.82 thousand -20.6%0.6%0.4 $3.40 12/31/202421,800 shares $71.94 thousand -26.4%0.8%0.6 $3.30 12/15/202429,600 shares $98.27 thousand -29.7%1.1%0.9 $3.32 11/30/202442,100 shares $137.25 thousand +6.1%1.5%1.6 $3.26 11/15/202439,700 shares $130.61 thousand -15.0%1.4%1.7 $3.29 10/31/202446,700 shares $168.12 thousand +1,197.2%1.8%1.7 $3.60 10/15/20243,600 shares $11.52 thousand -12.2%0.1%0.2 $3.20 9/30/20244,100 shares $15.01 thousand -21.2%0.2%0.2 $3.66 9/15/20245,200 shares $19.03 thousand -13.3%0.2%0.2 $3.66 8/31/20246,000 shares $22.20 thousand -34.8%0.2%0.2 $3.70 8/15/20249,200 shares $29.90 thousand -32.4%0.3%0.2 $3.25 7/31/202413,600 shares $62.97 thousand -24.4%0.5%0.4 $4.63 7/15/202418,000 shares $74.88 thousand -55.5%0.7%0.5 $4.16 6/30/202440,400 shares $169.68 thousand +11.6%1.5%1.2 $4.20 6/15/202436,200 shares $194.03 thousand +116.8%1.3%1.1 $5.36 5/31/202416,700 shares $74.10 thousand -74.9%0.6%0.7 $4.44 5/15/202466,500 shares $34.25 thousand -50.7%0.3%0.3 $0.52 4/30/2024135,000 shares $68.85 thousand +83.9%0.6%0.5 $0.51 4/15/202473,400 shares $41.10 thousand +48.3%0.3%0 $0.56 3/31/202449,500 shares $34.95 thousand -42.7%0.7%0 $0.71 3/15/202486,400 shares $55.22 thousand +51.6%1.2%0.1 $0.64 2/29/202457,000 shares $38.25 thousand -65.4%0.8%0 $0.67 2/15/2024164,500 shares $103.91 thousand -53.0%2.2%0.1 $0.63 1/31/2024349,800 shares $193.23 thousand -2.3%5.0%0.2 $0.55 1/15/2024358,100 shares $189.65 thousand +1.9%5.1%4 $0.53 12/31/2023351,300 shares $183.52 thousand -7.1%5.0%3.7 $0.52 12/15/2023378,300 shares $203.15 thousand -18.0%5.4%3.8 $0.54The Coin That Could Define Trump’s Crypto Presidency (Ad)When Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top advisor on crypto and AI. That alone signaled a shift. But insiders close to D.C. aren’t just talking crypto policy—they’re quietly buying something most retail investors have missed. While the crowd chases Bitcoin to $150,000, Weiss Ratings expert Juan Villaverde believes a different coin—already backed by giants like Google, Visa, and PayPal—could soon become crypto’s “Third Giant.”Discover the coin that could define Trump’s crypto presidency. 11/30/2023461,100 shares $238.53 thousand -14.6%6.6%4.5 $0.52 11/15/2023539,900 shares $312.01 thousand +67.3%7.8%4.7 $0.58 10/31/2023322,700 shares $191.68 thousand +15.0%4.9%1.1 $0.59 10/15/2023280,600 shares $179.29 thousand +4.9%4.3%1 $0.64 9/30/2023267,400 shares $151.80 thousand +5.9%4.1%0.9 $0.57 9/15/2023252,600 shares $136.15 thousand -30.6%3.8%0.8 $0.54 8/31/2023364,200 shares $179.11 thousand +398.9%5.4%1 $0.49 8/15/202373,000 shares $40.88 thousand -17.9%1.0%0.2 $0.56 7/31/202388,900 shares $52.45 thousand No Change1.3%0.3 $0.59 7/15/202388,900 shares $56.45 thousand +15.9%1.3%0.3 $0.64 6/30/202376,700 shares $49.31 thousand -37.4%1.3%0.3 $0.64 6/15/2023122,500 shares $98 thousand -33.4%2.2%0.6 $0.80 5/31/2023183,900 shares $386.19 thousand +99.9%3.3%1.1 $2.10 5/15/202392,000 shares $216.20 thousand +0.7%5.2%1.3 $2.35 4/30/202391,400 shares $405.82 thousand +13.4%5.4%0.1 $4.44 4/15/202380,600 shares $334.63 thousand -15.0%4.7%0.1 $4.15 3/31/202394,800 shares $316.63 thousand +96.3%5.6%0.1 $3.34 3/15/202348,300 shares $178.23 thousand -66.6%2.9%0 $3.69 2/28/2023144,500 shares $643.03 thousand -53.5%8.7%0.1 $4.45 2/15/2023310,600 shares $1.69 million +354.8%18.7%0.2 $5.45 1/31/202368,300 shares $241.10 thousand -47.1%4.3%0 $3.53 1/15/2023129,000 shares $476.01 thousand +737.7%8.2%0.5 $3.69 12/30/202215,400 shares $52.82 thousand -34.2%1.1%0 $3.43 12/15/202223,400 shares $79.33 thousand -18.8%2.5%0 $3.39 11/30/202228,800 shares $102.24 thousand -51.0%3.1%0.1 $3.55 11/15/202258,800 shares $363.38 thousand -30.6%6.4%0.1 $6.18 10/31/202284,700 shares $556.48 thousand +3.4%9.8%0.1 $6.57 10/15/202281,900 shares $504.50 thousand -42.7%9.2%0.1 $6.16 9/30/2022142,800 shares $878.22 thousand -97.6%N/A0.4 $6.15 9/15/20225,900,000 shares $1.33 million -16.7%N/A0.6 $0.22 8/31/20227,080,000 shares $1.38 million +1,993.4%45.6%0.8 $0.19 8/15/2022338,200 shares $52.42 thousand +545.4%6.2%0.1 $0.16 7/31/202252,400 shares $7.71 thousand -70.2%0.5%0.1 $0.15 7/15/2022176,000 shares $46.75 thousand +25.6%1.4%0.3 $0.27 6/30/2022140,100 shares $65.93 thousand -23.0%1.2%0.5 $0.47 6/15/2022182,000 shares $66.43 thousand -3.9%1.5%0.6 $0.37 5/31/2022189,400 shares $83.34 thousand No Change1.6%0.5 $0.44 5/15/2022189,400 shares $84.76 thousand -9.5%1.6%0.6 $0.45 4/30/2022209,200 shares $110.88 thousand +60.9%1.8%0.7 $0.53 4/15/2022130,000 shares $77.35 thousand -23.0%1.1%0.4 $0.60 3/31/2022168,900 shares $105.12 thousand -12.0%1.4%0.4 $0.62 3/15/2022191,900 shares $112.65 thousand +54.0%1.6%0.1 $0.59 2/28/2022124,600 shares $77.88 thousand -13.5%1.0%0 $0.63 2/15/2022144,000 shares $99.75 thousand -1.2%1.2%0.1 $0.69 1/31/2022145,700 shares $112.19 thousand -33.7%1.3%0.1 $0.77 1/15/2022219,900 shares $191.31 thousand +362.0%2.1%0.1 $0.87 12/31/202147,600 shares $71.88 thousand No Change0.5%0 $1.51 KPRX Short Interest - Frequently Asked Questions What is Kiora Pharmaceuticals' current short interest? Short interest is the volume of Kiora Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of July 31st, investors have sold 25,100 shares of KPRX short. 0.89% of Kiora Pharmaceuticals' shares are currently sold short. Learn More on Kiora Pharmaceuticals' current short interest. What is a good short interest percentage for Kiora Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.89% of Kiora Pharmaceuticals' floating shares are currently sold short. Is Kiora Pharmaceuticals' short interest increasing or decreasing? Kiora Pharmaceuticals saw a decrease in short interest in the month of July. As of July 31st, there was short interest totaling 25,100 shares, a decrease of 51.5% from the previous total of 51,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Kiora Pharmaceuticals' float size? Kiora Pharmaceuticals currently has issued a total of 3,430,000 shares. Some of Kiora Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Kiora Pharmaceuticals currently has a public float of 2,820,000 shares. How does Kiora Pharmaceuticals' short interest compare to its competitors? 0.89% of Kiora Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Kiora Pharmaceuticals: Iterum Therapeutics PLC (4.76%), Mersana Therapeutics, Inc. (8.01%), Xilio Therapeutics, Inc. (21.31%), Estrella Immunopharma, Inc. (1.61%), RenovoRx, Inc. (0.25%), SCYNEXIS, Inc. (1.40%), Clearside Biomedical, Inc. (2.70%), Akari Therapeutics PLC (0.15%), Mural Oncology PLC (2.01%), BioXcel Therapeutics, Inc. (4.84%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), Strategy Inc ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks. What does it mean to sell short Kiora Pharmaceuticals stock? Short selling KPRX is an investing strategy that aims to generate trading profit from Kiora Pharmaceuticals as its price is falling. KPRX shares are trading up $0.11 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Kiora Pharmaceuticals? A short squeeze for Kiora Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of KPRX, which in turn drives the price of the stock up even further. How often is Kiora Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KPRX, twice per month. The most recent reporting period available is July, 31 2025. More Short Interest Resources from MarketBeat Related Companies ITRM Short Interest MRSN Short Interest XLO Short Interest ESLA Short Interest RNXT Short Interest SCYX Short Interest CLSD Short Interest AKTX Short Interest MURA Short Interest BTAI Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:KPRX) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kiora Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kiora Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access